常用复苏药物和方法的临床应用评价

发布时间：2019-04-21 10:17

【摘要】：新的战场救治更强调“医疗与士兵同在”,而战场上医疗的第一原则是救命,生命复苏。临床研究进一步评价了传统的复苏药物和方法在临床应用中的实际效果,如肾上腺素与血管加压素复苏效果的比较,利多卡因不再作为预防性用药使用于急性心肌梗死中,胺碘酮经大规模临床研究被证实为心衰患者和对除颤及肾上腺素无效的心脏停搏患者的首选用药。限制性液体复苏概念重新审视了以住对失血性休克的快速补液疗法,晶体液、胶体液和高渗盐水对危重和创伤患者应用的利弊仍需临床研究探讨。
[Abstract]:New battlefield care emphasizes "medical care with soldiers", and the first principle of battlefield medical care is life-saving and life recovery. Clinical studies have further evaluated the practical effects of traditional resuscitation drugs and methods, such as epinephrine and vasopressin, and lidocaine is no longer used as a preventive drug in acute myocardial infarction. Amiodarone has been proven to be the first choice for patients with heart failure and cardiac arrest with no effect on defibrillation and epinephrine by large-scale clinical studies. The concept of restricted fluid resuscitation reexamined the advantages and disadvantages of rapid fluid replacement therapy for hemorrhagic shock, crystalloid, colloid and hypertonic saline for critical and traumatic patients.
【作者单位】：解放军总医院急诊科
【分类号】：R82

【相似文献】